Objective To assess the effectiveness of Cogmed Working Memory Training compared with a placebo program in improving academic functioning 24 months post-training in extremely preterm/extremely low birth weight 7-year-olds.
Cogmed Working Memory Training is a widely used commercial working memory training program, suggested to improve working memory, attention, executive functioning, and basic educational skills in the short term. [11] [12] [13] Preterm research outcomes with Cogmed have generally been positive, though limited to 3 small, nonrandomized studies with sample sizes ranging from 12 to 20.
14-17 All 3 studies (2 in preschoolers and 1 in adolescents) reported training-related memory benefits persisting up to 7 months, [14] [15] [16] [17] as well as improvements in auditory attention and phonemic awareness. 14, 17 Training benefits to academics and everyday behavior have not been explored in extremely preterm children, and further research is needed to examine these outcomes, preferably with larger, double-blind, placebo-controlled randomized controlled trials. 18 Training-induced improvement should not be assumed given recent evidence from a large population-based randomized controlled trial of Cogmed in children with low working memory that reported little long-term benefit for working memory or academic functioning compared with usual classroom teaching. 19 This randomized controlled trial aimed to assess the effectiveness of Cogmed in extremely preterm/ extremely low birth weight (ELBW; birth weight <1000 g) 7-year-olds to improve academic functioning up to 24 months post-training, compared with a placebo training program.
Methods
This study was a double-blind, placebo-controlled, randomized trial of the Cogmed program with 7-year-old children born extremely preterm and/or ELBW called the Improving Memory in a Preterm Randomized Intervention Trial. 20 Improving Memory in a Preterm Randomized Intervention Trial is registered with the Australian New Zealand Clinical Trials Registry (ACTRN 12612000124831) and approved by the relevant Human Research and Ethics Committees. The trial was conducted and reported in accordance to CONSORT guidelines (Figure 1 and Supplement; available at www.jpeds.com), and written consent was obtained from the primary caregiver of participating children.
The 2005 Victorian Infant Collaborative Study cohort comprised all children born extremely preterm or ELBW in the state of Victoria in 2005 who did not have a congenital abnormality known to affect neurodevelopment. These children were invited to take part in the trial at their 7-year follow-up appointment from June 2012 to April 2014. 21 Of the 221 children in the cohort, 172 (78%) attended their 7-year neuropsychological follow-up assessment during the recruitment window and were informed of the trial. Children were excluded if a severe intellectual, sensory, or physical impairment affected their capacity to complete or understand the training, if the family had relocated or were unable to assist them through the program, or if the child had previous exposure to Cogmed (Figure 1) . Of the 151 eligible children, 91 children enrolled and participated in the trial (60%).
Initial sample size calculations based on 80% power and a type 1 error rate of 5%, determined that a sample of 63 participants in each treatment arm (126 in total) would detect a difference of 0.5 SD in our primary outcome (academic functioning) 24 months post-training between the Cogmed and placebo groups. 20 We failed to achieve our proposed sample size because of unexpected challenges during recruitment and a lower than anticipated rate of eligibility (Figure 1) .
Procedure
Participants completed a baseline assessment of general cognitive function, working memory, attention, behavior, and academic functioning. Participants were subsequently randomized to either the Cogmed (intervention) or placebo groups in a 1:1, using block randomization with variable block sizes, stratified by singleton vs surviving multiple births (twins/triplets) and "low" vs "age-typical" working memory capacity at the baseline assessment. Surviving twins and triplets were allocated to the same intervention group to reduce contamination, and low working memory capacity was defined as a score less than or equal to the 20th percentile on the Backward Digit Recall subtest from the Working Memory Test Battery for Children. 22 Participants were allocated the next available sequential number in the required strata, which corresponded to an opaque envelope containing the treatment allocation managed by the project coordinator and trial's research assistant. A biostatistician who was independent of the study generated the randomization schedule. The Cogmed and placebo interventions were undertaken in the home, and participants and their families remained blinded to treatment allocation throughout the study. The primary outcome measure was collected 24 months following training, with 2 interim assessments at 2 weeks and 12 months post-training (Table I provides more information on the trial's secondary outcomes measures). Assessments were conducted at the Murdoch Children's Research Institute in Melbourne by blinded assessors.
Intervention
The trial employed the RM version of Cogmed designed for children aged 7 years and above. The training program comprises a recommended 20-25 training sessions completed over a 5-to 7-week period. Each training session takes 35-50 minutes and comprises 8 different interactive, computerized working memory activities. 20 Some important features of Cogmed are that training is (1) adaptive, and matches the difficulty level of each activity based on the child's current performance on that activity on a trial-by-trial basis; (2) based on implicit learning; and (3) designed to be engaging and fun with built-in positive reinforcement. The placebo program was a nonadaptive version of Cogmed, designed for the purpose of trial evaluations. The placebo program is identical to Cogmed except the activities are set to a low level of complexity throughout the training period to ensure the training does not tax working memory. Table I summarizes the outcome measures of the trial. Our primary outcome measure of academic functioning was assessed across 4 domains of word reading, sentence comprehension, spelling, and math computation ( Table I) . Secondary outcomes measures included working memory, attention, behavior, and general cognitive ability ( Table I) . Perinatal data were collected from the child's medical record, and social risk was assessed using a social risk index (range 0-12). 23 Social risk scores were dichotomized with scores <2 classified as lower social risk, and those >2 classified as higher social risk. 24 
Measures

Statistical Analyses
Data were analyzed using Stata v 14.0 (StataCorp, College Station, Texas) and an intention-to-treat approach. 25 Treatment effects for academic, cognitive, and behavioral outcomes at each time point were assessed using a single mixedeffects regression model for each outcome applied to the baseline, 2-week, 12-month, and 24-month time points. Models included a random effect for participants to allow for the clustering of repeated observations within an individual, a separate intervention effect at each follow-up time point, and a separate residual term at each of the 4 measurement time points. This approach accounts for missing data by enabling all participants with baseline data, equivalent to all participants, to be included in the analysis. Results were adjusted for working memory performance at baseline (normal vs low) and surviving multiple versus singleton birth as used in the randomization. Secondary analyses were performed adjusted for sex, Volume 202 • November 2018 social risk, and general cognitive ability as potentially important confounders. A sensitivity analysis was conducted, which was restricted to participants who completed at least 20 training sessions in line with Cogmed recommendations.
Results
Demographic and Training Characteristics
Demographic and clinical characteristics were similar between study participants and eligible nonparticipants (n = 60) except for gestational age, which was higher in participants than nonparticipants (27.1 weeks on average vs 26.4 weeks). Characteristics were also similar between treatment groups at baseline (Table II) . Participants in the Cogmed group completed 19 training sessions on average (SD 7.7, range 1-25) across the training period, compared with 21 sessions (SD 6.7, range 2-25) in the placebo group. Thirty children (67%) in the Cogmed group completed ≥20 sessions, compared with 37 (80%) children in the placebo group. The average length of training was 6.2 weeks (SD 1.0) in the Cogmed group and 6.0 weeks (SD 1.2) in the placebo group. Figure 2 summarizes the outcome comparisons between Cogmed and placebo groups. In terms of the primary outcome, there was little evidence of a group difference in academic achievement 2 weeks, 12 months, or 24 months post-training. Similarly, there was little evidence of a treatment benefit for working memory, immediate memory, attention, or behavioral outcomes at the 3 follow-up time points (Table III ; available at www.jpeds.com). In the secondary analyses, adjustment for sex, social risk, and general cognitive ability had little effect on treatment group differences for all outcomes in the secondary analyses (Table IV ; available at www.jpeds.com). The sensitivity analyses (restricted to children who completed ≥20 training sessions) indicated weak evidence of greater spelling performance (p = .06) and immediate verbal memory (Digit Recall, p = .09) in the Cogmed group compared with the placebo group at 2 weeks post-training. However, the evidence for these differences was not maintained at 12 or 24 months post-training (Figure 3 [available at www.jpeds.com] and Table V) .
Outcomes
Discussion
In contrast to previous studies in preterm cohorts, we found little evidence of short-or long-term benefits of Cogmed on academic functioning, working memory, attention, or behavioral outcomes. These findings are of relevance because computerized cognitive training programs like Cogmed are popular tools for cognitive enhancement, with benefits reported across a range of domains. Our findings lead us to conclude that the use of Cogmed at early school age in extremely preterm/ ELBW children is not effective in improving outcomes for these children.
Previous Cogmed studies with preterm preschoolers and adolescents, which reported benefits, were not randomized controlled trials and had small samples.
14-17 Benefits observed in training studies that adopt nonrobust methodologies and small samples may be attributed to extraneous factors, 18 rather than cognitive training. The gold standard for determining intervention effectiveness is double-blind, placebo-controlled, randomized designs with an intention-to-treat analytic approach, 18 and our study is the first to meet this recommendation in extremely preterm/ELBW children.
In our trial, we wished to evaluate the adaptive feature of continuous adjustment of difficulty level according to performance of Cogmed training. Therefore, we used an active control condition in which the control group received the same intervention as the Cogmed group, except the working memory load was set to a low level. In contrast, previous studies of Cogmed in preterm children have employed passive control (usual care, no training), 17 waitlist control, 14 or term born control (completed Cogmed) 15, 16 conditions. This may have contributed to differences in the outcomes of the studies.
A further difference is that previous preterm studies recruited younger or older preterm individuals rather than early school-age children as in the present study. 14, 17 Given that working memory capacity undergoes considerable growth and development during the early to middle childhood years, the benefits of Cogmed may vary depending on the age at administration. Evidence from meta-analyses of working memory training is mixed, with a trend for stronger training benefits at younger ages in typically developing children (4-13 years), 8 but greater benefit reported at older ages (>10 years) in children and adolescents with learning difficulties. 26 Working memory training has been reported to benefit academic functioning and behavior (far-transfer effects). [27] [28] [29] As parents are likely to enroll their children in programs like Cogmed to improve educational outcomes and behavior, the primary outcome of our trial was academic functioning. Several trials have reported no short-term 30, 31 or long-term 19, 32 improvements in literacy and numeracy performance following Cogmed, consistent with our findings. Thus, the weight of evidence from high-quality studies suggests that Cogmed does not improve academic functioning.
The evidence for benefits of Cogmed on behavior is mixed, 18, 33 and compromised by small, nonrandomized controlled studies and unblinded raters. There is some evidence that Cogmed reduces inattentive or attention deficit hyperactivity disorder symptoms as reported by caregivers, 33 even in preterm samples. 14, 15 However, caregivers are often invested in the training, and bias may alter their perceptions and ratings of their child's inattentive behavior following training. There is little evidence that Cogmed benefits socioemotional or executive behaviors, 18, 19 consistent with our findings. Similarly, we found little evidence that Cogmed benefited cognitive attention outcomes. Absence of gains in academic functioning, behavior, and attention may be expected if no working memory gains are observed.
Strengths of our study are that we used blinded treatment allocation and outcome assessments, assessed short-and longterm outcomes, recruited a large sample, achieved an excellent retention rate (87%-97%), analyzed the data on an intentionto-treat basis, and accounted for child factors known to influence training outcomes (baseline working memory and general cognitive ability). A limitation was the lower than anticipated levels of training compliance from participants. Analyses restricted to those who completed training generally revealed our primary results to be robust, although these sensitivity analyses found weak evidence that the Cogmed group performed better on tests of spelling and immediate verbal memory (Digit Recall) 2 weeks after training compared with the placebo group. Another limitation was a smaller than desired sample, but group differences were small and potentially not clinically meaningful. Finally, we did not assess the influence of factors such as the home environment, caregiver involvement, and training motivation, which may contribute to training outcomes. [34] [35] [36] On the basis of the present findings, we cannot currently recommend Cogmed for cognitive enhancement in extremely preterm/ELBW early school-age children. However, we acknowledge that interindividual variability in response to cognitive training is likely. 35, 37 Future studies should investigate individual differences on training outcomes, as subgroups of individuals may benefit more than others. [38] [39] [40] It may be that greater success with working memory training will come from integrating different intervention approaches that target various mechanisms and processes involved in learning. 41 In conclusion, our randomized controlled trial provides little support that Cogmed is efficacious for improving academic functioning 24 months post-training in extremely preterm/ ELBW early school-aged children. Detailed investigations are now needed to evaluate if Cogmed is efficacious for specific subgroups of children. ■ 3 (7) 6 (13) IVH, grade III/IV, n (%) 3 (7) 2 (4) Cystic PVL, n (%) 1 (2) 1 (2) Corrected age at assessment (years), M (SD) 7.6 (0.4) 7.6 (0.4) Cerebral palsy at age 7-8 years, n (%) 4 (9) . Treatment group differences in academics, working memory, immediate verbal memory, immediate visual-spatial memory, attention, and behavior at 2 weeks, 12 months, and 24 months post-training. Point estimates reflect regression coefficients from mixed-effect models where a group difference >0 reflects a higher score in the Cogmed group, and a group difference <0 reflects a lower score in the Cogmed group. Vertical error bars represent 95% CIs.
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Volume 202 Figure 1 . CONSORT diagram of participant flow. Sixteen children were excluded for severe intellectual, sensory, or physical impairments that affected their capacity to complete or understand the training; 2 had families unable to assist them through the program; 2 relocated during the trial period; 1 had previous exposure to Cogmed.
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97.e1 Figure 3 . Sensitivity analysis of treatment group differences in academics, working memory, immediate verbal memory, immediate visual-spatial memory, attention, and behavior at 2 weeks, 12 months, and 24 months post-training in participants who completed ≥20 sessions of training (n = 30 in Cogmed group and n = 37 in placebo group). Point estimates reflect regression coefficients from mixed-effect models where a group difference >0 reflects a higher score in the Cogmed group, and a group difference <0 reflects a lower score in the Cogmed group. Vertical error bars represent 95% CIs.
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